ijms-logo

Journal Browser

Journal Browser

Advances in Magnetic Resonance Imaging in Diagnostics

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (1 April 2024) | Viewed by 2670

Special Issue Editor


E-Mail Website
Guest Editor
Department of Biomedical Imaging and Image-Guided Therapy, Medizinische Universität Wien, 1090 Vienna, Austria
Interests: diagnostic imaging; pediatric radiology; abdomen MR imaging; lunge MR imaging; MR-urography; MRI safety; gadolinium-based contrast agent; radiation protection; computed tomography; diagnostic radiography

Special Issue Information

Dear Colleagues,

Today, magnetic resonance imaging (MRI) with and without gadolinium-based contrast agents (GBCA) is an inseparable tool in the diagnosis and follow-up of patients e.g. after trauma, infections, stroke and oncological diseases, as well as in patients with chronic inflammatory, degenerative or functional disorders, both children and in adults. MRI is an important tool in prenatal diagnostics. In addition to established MRI sequences, new faster sequences are continously being developed, promising shorter scans that reduce the need for sedation in young children and also enable more comfortable scans in adults. Developments in the hybrid PET-MRI improve the treatment of oncological patients. Gadolinium in GBCAs is chelated with organic chelating agents. The toxic side effect of GBCAs due to the release of free Gd3+ ions from the chelating agents and gadolinium deposition in bone, brain and kidneys after repeated use of GBCAs as well as the reported development of nephrogenic systemic fibrosis (NSF) require new strategies to stabilize Gd3+ ions in chelating agents to increase their stability, biocompatibility and pharmacokinetics and thereby improve their safety profile. Bioresponsive GBCAs have the potential to visualize biochemical processes, such as gene expression, neuronal signaling, and hormone secretion. The challenge, to make MRI with bioresponsive GBCAs fit for non-invasive diagnostic and theranostic applications, required collaborations between researchers from chemistry, biology and biomedical engineering as well as clinicians.

As the Guest Editor of this Special Issue, “Advances in Magnetic Resonance Imaging in Diagnostics”, in IJMS, I expect submissions from many researchers working on the wide spectrum of MRI, PET-MRI, moleculare imaging, as well as GBCAs engineering. The focus of this topic is the new MRI tools, new GBCAs, bioresponsive GBCAs and MRI and GBCA safety as well as application of artifificial intenligence (AI). The formats for submissions include original research, reports, reviews, perspectives/opinions and methodology articles.

Dr. Azadeh Hojreh
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 5062 KiB  
Article
Non-Contrast MR Lymphography and Intranodal Dynamic Contrast MR Lymphangiography in Children with Congenital Heart Disease—Imaging Findings as well as Impact on Patient Management and Outcome
by Christoph Bauer, Mario Scala, Pavel Sekyra, Franz Fellner and Gerald Tulzer
Int. J. Mol. Sci. 2023, 24(19), 14827; https://doi.org/10.3390/ijms241914827 - 2 Oct 2023
Cited by 2 | Viewed by 2016
Abstract
Lymphatic flow disorders are rare but devastating complications in children with congenital heart disease. T2-weighted magnetic resonance lymphography and intranodal dynamic contrast magnetic resonance lymphangiography are imaging modalities that can depict central lymphatic anatomy and flow pattern. Our objective was to describe the [...] Read more.
Lymphatic flow disorders are rare but devastating complications in children with congenital heart disease. T2-weighted magnetic resonance lymphography and intranodal dynamic contrast magnetic resonance lymphangiography are imaging modalities that can depict central lymphatic anatomy and flow pattern. Our objective was to describe the technical aspects and our imaging findings of central lymphatic abnormalities and their impact on patient management and outcomes: We conducted a retrospective review of 26 children with congenital heart disease who presented for lymphatic imaging between 2015 and 2020 at our institution. Eleven had postoperative chylothorax, six had plastic bronchitis, seven had protein-losing enteropathy and three had Noonan syndrome. Our lymphatic imaging demonstrated severely abnormal lymphatic flow in all of the children, but only minor abnormalities in protein-losing enteropathy. No major procedure-related complication occurred. Lymphatic interventions were performed in six patients, thoracic duct decompression in two patients and chylothorax revision in three patients. This led to symptomatic improvements in all of the patients: Lymphatic imaging is safe and essential for the diagnosis of lymphatic flow disorders and therapy planning. Our intranodal lymphangiography depicts an abnormal lymphatic flow pattern from the central lymphatics but failed to demonstrate an abnormal lymphatic flow in protein-losing enteropathy. These imaging techniques are the basis for selective lymphatic interventions, which are promising to treat lymphatic flow disorders. Full article
(This article belongs to the Special Issue Advances in Magnetic Resonance Imaging in Diagnostics)
Show Figures

Figure 1

Back to TopTop